Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.

Bullboard (GREY:IMVIF)

View:
Comment by Lambomon Mar 01, 2021 6:49pm

RE:3 milestones Q1 2021

What was it in the premarket this am?
Post by Biotech010on Mar 01, 2021 2:58pm

3 milestones Q1 2021

lots of news coming! Lets hope the FDA will agree with a fast path to market! The stock jumped 40% higher this morning in pre market trading..... And with the conference next week... I'm pretty ...more  
Comment by Biotech010on Feb 25, 2021 12:25pm

RE:RE:RE:Email management

no pumping just the truth.
Comment by alphaseeking001on Feb 25, 2021 11:02am

RE:Updated page?

I don't believe that little synopsis about the DPx "platform" was on the website before.  They modify the site with reasonable frequency.  
Post by LR6852on Feb 25, 2021 10:44am

Updated page?

Does anyone know if this is new? https://www.imv-inc.com/the-dpx-platform
Comment by alexmed95on Feb 24, 2021 6:53pm

RE:RE:RE:Email management

Damn where have you been since QM45 f*** you over ? It was too calm here. Welcome back !
Comment by pumpbuster2011on Feb 24, 2021 6:31pm

RE:RE:Email management

Not worried! I talk to Fred a lot too.  .. like a lot lot. So more than your "a lot". He said, the deal is done; you know, ink isn;t dry yet, but they are partnering with Merck. Anyway, ...more  
Comment by alexmed95on Feb 24, 2021 3:39pm

RE:RE:Email management

I hope you are right my friend! Would be nice to be rewarded after such a long commitment. 
Comment by Biotech010on Feb 24, 2021 2:11pm

RE:RE:Email management

in addition, the meeting with the FDA has taken place to discuss the next path for DLBCL. I guess the final details with Merck are now being discussed.
Comment by Biotech010on Feb 24, 2021 12:17pm

RE:Email management

i talk to Fred a lot... no need to worry people. Everything is on track and they will report on the milestones mentioned in the latest IR presentation.
Post by Lambomon Feb 24, 2021 9:51am

Email management

May be a good time for everyone to send an email to management. It seems they just don't care , missing deadlines /etc. this is ridiculous how they manage things ... they need a great showman.
Post by qwerty22on Feb 24, 2021 7:13am

QandA

https://www.drugdiscoverytrends.com/qa-why-imvs-dpx-survivac-shows-promise-in-treating-ovarian-cancer/ Pretty dull, giving nothing new away.
Comment by qwerty22on Feb 23, 2021 2:37pm

RE:RE:RE:RE:Another Ball dropped

They don't need VR at this point to prove anything, they need to make solid progress with the regulators. I'm happy if 100% of their attention is on that.  
Comment by alphaseeking001on Feb 23, 2021 1:21pm

RE:RE:RE:Another Ball dropped

Thanks again QM45! I seriously hope they deliver soon.  
Comment by QM4455on Feb 23, 2021 1:05pm

RE:RE:Another Ball dropped

Yes I was Alpha,  But you have to be able to seperate science from investement. Mr. Pemberton died peniless from his Coca-Cola invention...  If they got the updates out or some progress ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities